- Case report
- Open Access
- Open Peer Review
Osteomyelitis of a long bone due to Fusobacterium nucleatum and Actinomyces meyeriin an immunocompetent adult: A case report and literature review
© Lee et al.; licensee BioMed Central Ltd. 2012
- Received: 26 March 2012
- Accepted: 6 July 2012
- Published: 20 July 2012
Fusobacterium species are uncommon causes of osteomyelitis. These organisms are normal flora of the oral cavity. Therefore, they mostly cause osteomyelitis of the head and neck. Hematogenous osteomyelitis at distant sites other than the head and neck has rarely been reported in pediatric or immunocompromised patients. Here, we report the first case of osteomyelitis of a long bone combined with a muscle abscess due to Fusobacterium nucleatum in an otherwise healthy adult.
A 59-year-old Korean man was admitted for pain and swelling of the right lower leg, which had been persistent for two weeks. Magnetic resonance imaging showed osteomyelitis of the right fibula with a surrounding muscle abscess of the right lower leg. Incision and drainage was performed, and repetitive tissue cultures grew F. nucleatum. In this patient, it was presumed that recurrent periodontitis caused hematogenous seeding of F. nucleatum to a distant site leading to osteomyelitis with a muscle abscess. The patient was successfully treated with intravenous ampicillin-sulbactam for three weeks and oral amoxicillin-clavulanate for eight weeks. He also underwent repeated surgical drainage. He has no evidence of recurrence after seven months of follow-up.
Clinicians should be aware that F. nucleatum could be the etiologic agent of hematogenous osteomyelitis of a long bone in an immunocompetent patient.
- Fusobacterium nucleatum
Fusobacterium species are gram-negative bacilli that are nonmotile, non-sporulating, obligate anaerobes from the family Bacteroidaceae . They have frequently been isolated from a wide variety of clinically significant anaerobic infections, including oral and dental infections, brain abscesses, bacteremia, endocarditis, and soft tissue infections [2–5]. Only occasionally have Fusobacterium species been isolated from bone and joint infections. They are part of the normal flora of the oral cavity, gastrointestinal tract, upper respiratory tract, and female genital tract . They are mostly found in the mouth and are discovered to a lesser extent in feces and the urogenital tract . Therefore, reported cases of osteomyelitis caused by Fusobacterium spp. were mostly in the head and neck area. These were associated with chronic periodontitis or an odontogenic abscess and resulted from contiguous spread of the infection. For cases of osteomyelitis resulting from hematogenous seeding, most patients were children or had predisposing factors that could easily lead to osteomyelitis. Such risk factors include indwelling intravascular catheters, distant foci of infection, intravenous drug abuse, vascular insufficiency, sickle cell disease, traumatic bone injury, open fractures, or chronic soft tissue infections [1, 4–8]. Our literature review revealed that there are no reports of long bone osteomyelitis caused by Fusobacterium spp. in immunocompetent adults. Here we describe a case of fibular osteomyelitis combined with muscle abscess caused by F. nucleatum in an adult patient with no known predisposing factors.
A 59-year-old previously healthy man presented with fever and pain and swelling in his right lower leg. About two months before this admission, he had developed pain in his right lower leg. The pain had progressively worsened despite analgesics, and his right lower leg had begun to swell. About two weeks before this admission, he had been admitted to an outside hospital where he was found to have osteomyelitis of the right fibula combined with abscesses of adjacent muscles (soleus, tibialis posterior, and fibularis longus). He underwent incision and drainage of his right leg. A first generation cephalosporin was started empirically. However, repeated cultures from tissues had grown no microorganisms, and the leg had been draining pus persistently up until transfer to our hospital. The patient was transferred to our hospital for further diagnostic evaluation and treatment.
His past medical history was negative for diabetes mellitus, arterial hypertension, alcoholism, steroid use, and any other systemic infections. He has been smoking one packet of cigarettes a day for 15 years. He denied a history of local trauma or recreational drug abuse. He recalled recurrent periodontitis lasting for ten years. Approximately three months before presentation, he had four teeth extracted and dentures implanted. He did not receive prophylactic antibiotics before the tooth extraction.
Incision and drainage were performed at the bedside and tissues were sent for Gram staining and culture. Intravenous ampicillin-sulbactam was started at 3 g every six hours. On hospital day 3, fibular excision was performed due to the severe osteomyelitis. Findings on microscopic examination of the bone biopsy specimen were consistent with acute osteomyelitis and showed necrotic tissue with microabscess. Initial tissue culture at our hospital revealed F. nucleatum and Actinomyces meyeri as the causative organisms. Tissue cultures performed at the outside hospital also reportedly grew Fusobacterium spp. in two out of five specimens. The patient had repeat incision and debridement surgery on hospital day 7 and day 17. Intravenous ampicillin-sulbactam was administered for three weeks and then switched to oral amoxicillin-clavulanate at 625 mg every 8 h for eight weeks. Antibiotics were discontinued after 11 weeks of successful treatment. His recovery has been uneventful without recurrence of infection after seven months of follow-up.
Anaerobes have traditionally been viewed as uncommon causes of osteomyelitis because they are difficult to isolate from infectious sites due to their fastidious nature. However, due to the development of methods for detecting anaerobes, reports of anaerobic osteomyelitis have been increasing; up to 39% of cases of osteomyelitis were associated with anaerobic infections in a previous study . Anaerobic osteomyelitis has typically been reported in patients with complicated bone fractures or underlying chronic disease, usually as a result of non-hematogenous spread. The predominant anaerobes causing osteomyelitis are Bacteroides spp., Peptostreptococcus spp., Fusobacterium spp., Clostridium spp. and Propionibacterium acnes[9, 10].
Fusobacterium spp. are commonly found in periodontal disease, and they are known to produce tissue irritants such as butyric acid, proteases, and cytokines. They have strong adhesive properties due to the presence of lectins. These outer membrane proteins mediate adhesion to epithelia and tooth surfaces and coagglutination with other suspected pathogens .
Cases of osteomyelitis caused by Fusobacterium spp. reported in the medical literature
Murray et al.
Sickle cell disease
Nafcillin + Ceftriaxone → Clindamycin 6w (IV)
Beauchamp et al.
Clindamycin 10 w (IV 4w, PO 6w)
Le Moal et al.
Recent dental work
Blood and tissue
Clindamycin 12 w (IV 4w, PO 8w)
Amoxicillin-clavulanic acid → Clindamycin 8w (IV 4w, PO 4w)
Diabetes mellitus, Arterial hypertension
Blood and tissue
Penicilin G 4w (IV) → Clindamycin 8w (PO)
Sanchez et al.
Imipenem → Amoxicillin-clavulanic acid 6w
Stahlman et al.
Penicilin G 6w (IV)
Management of osteomyelitis includes symptomatic therapy, immobilization for some patients, adequate drainage of purulent material, and antibiotic therapy consisting of parenteral administration of antibiotics for at least four to eight weeks. In some cases, even longer antibiotic treatment is necessary . Fusobacterium spp. are commonly sensitive to the usual anti-anaerobic antibacterial agents including penicillin G, clindamycin, metronidazole, chloramphenicol, imipenem, and cefoxitin . However, there is evidence of emerging resistance of some Fusobacterium spp. isolates to penicillins, carbapenems, and clindamycin [13, 15]. The first description of a β-lactamase in Fusobacterium spp. was reported in 1985, and this was shown to primarily be a penicillinase with little activity against cephalosporins . Since then, several studies have reported β-lactamase production by Fusobacterium spp. Fatal sepsis due to a β-lactamase-producing strain occurred in an immunocompromised patient . In studies done from 1999 to 2008, 0–14.6% of Fusobacterium spp. isolates were found to be nonsusceptible to penicillin [17–24]. The nonsusceptibility to β-lactam-β-lactamase inhibitors was found to be much lower (0-3.3%) [18–22]. There were regional differences between species in terms of penicillin resistance, but resistance to β-lactam-β-lactamase inhibitors was similarly low in different regions . Recently, as Bacteroides spp. have become more resistant to carbapenem, carbapenem resistance in Fusobacterium spp. has also been reported. In a study from Taiwan, 4% of Fusobacteria isolates were “nonsusceptible” to imipenem and 8% were “nonsusceptible” to meropenem . Our patient was successfully treated with β-lactam-β-lactamase inhibitors. The duration of antibiotic therapy is debated, but prolonged duration of high-dose β-lactam therapy is recommended because of the endovascular nature of the infection. Surgical debridement is crucial given the tendency toward abscess formation .
We reported the first case of osteomyelitis caused by F. nucleatum in an adult patient with no definite risk factors for hematogenous osteomyelitis. It is believed that in this patient, recurrent periodontitis might have been the source of bacteremia. Efforts to isolate anaerobic pathogens should be made in patients with characteristics of anaerobic infections, such as large abscesses.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Series Editor of this journal.
- Naredo Sanchez E, de Cal IW, Alegre Bernal N, Martin Rodrigo MD, Jaeger JU, Del Pozo FC, Blanco AJ, Valenciano AC, Echevarria MC: Fusobacterium osteomyelitis of the pubic symphysis in a healthy soccer player. J Rheumatol. 2000, 27 (8): 2047-2048.PubMedGoogle Scholar
- Brook I: Fusobacterial infections in children. J Infect. 1994, 28 (2): 155-165. 10.1016/S0163-4453(94)95600-6.View ArticlePubMedGoogle Scholar
- Roberts GL: Fusobacterial infections: an underestimated threat. Br J Biomed Sci. 2000, 57 (2): 156-162.PubMedGoogle Scholar
- Murray SJ, Lieberman JM: Fusobacterium osteomyelitis in a child with sickle cell disease. Pediatr Infect Dis J. 2002, 21 (10): 979-981. 10.1097/00006454-200210000-00020.View ArticlePubMedGoogle Scholar
- Beauchamp RD, Cimolai N: Osteomyelitis of the pelvis due to Fusobacterium nucleatum. Canadian journal of surgery Journal canadien de chirurgie. 1991, 34 (6): 618-620.PubMedGoogle Scholar
- Le Moal G, Juhel L, Grollier G, Godet C, Azais I, Roblot F: Vertebral osteomyelitis due to Fusobacterium species: report of three cases and review of the literature. J Infect. 2005, 51 (2): E5-9. 10.1016/j.jinf.2004.06.012.View ArticlePubMedGoogle Scholar
- Stahlman GC, DeBoer DK, Green NE: Fusobacterium osteomyelitis and pyarthrosis: a classic case of Lemierre's syndrome. J Pediatr Orthop. 1996, 16 (4): 529-532. 10.1097/01241398-199607000-00022.View ArticlePubMedGoogle Scholar
- Wald ER: Risk factors for osteomyelitis. Am J Med. 1985, 78 (6B): 206-212.View ArticlePubMedGoogle Scholar
- Lewis RP, Sutter VL, Finegold SM: Bone infections involving anaerobic bacteria. Medicine. 1978, 57 (4): 279-305.View ArticlePubMedGoogle Scholar
- Brook I, Frazier EH: Anaerobic osteomyelitis and arthritis in a military hospital: A 10 year experience. Am J Med. 1993, 94 (1): 21-28. 10.1016/0002-9343(93)90115-6.View ArticlePubMedGoogle Scholar
- Han XY, Weinberg JS, Prabhu SS, Hassenbusch SJ, Fuller GN, Tarrand JJ, Kontoyiannis DP: Fusobacterial brain abscess: A review of five cases and an analysis of possible pathogenesis. J Neurosurg. 2003, 99 (4): 693-700. 10.3171/jns.2003.99.4.0693.View ArticlePubMedGoogle Scholar
- Germann G, Petracic A, Wittemann M, Raff T: Hematogenous osteomyelitis of the hand skeleton in adults after dental maxillary infections. Ann Plast Surg. 1996, 37 (1): 106-110. 10.1097/00000637-199607000-00016.View ArticlePubMedGoogle Scholar
- Brook I: Microbiology and management of joint and bone infections due to anaerobic bacteria. Journal of orthopaedic science: official journal of the Japanese Orthopaedic Association. 2008, 13 (2): 160-169. 10.1007/s00776-007-1207-1.View ArticleGoogle Scholar
- Williams MD, Kerber CA, Tergin HF: Unusual presentation of Lemierre's syndrome due to Fusobacterium nucleatum. J Clin Microbiol. 2003, 41 (7): 3445-3448. 10.1128/JCM.41.7.3445-3448.2003.View ArticlePubMedPubMed CentralGoogle Scholar
- Bennett KW, Eley A: Fusobacteria: New taxonomy and related diseases. J Med Microbiol. 1993, 39 (4): 246-254. 10.1099/00222615-39-4-246.View ArticlePubMedGoogle Scholar
- Goldstein EJ, Summanen PH, Citron DM, Rosove MH, Finegold SM: Fatal sepsis due to a beta-lactamase-producing strain of Fusobacterium nucleatum subspecies polymorphum. Clinical infectious diseases: An official publication of the Infectious Diseases Society of America. 1995, 20 (4): 797-800. 10.1093/clinids/20.4.797.View ArticleGoogle Scholar
- Liu CY, Huang YT, Liao CH, Yen LC, Lin HY, Hsueh PR: Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems. Antimicrob Agents Chemother. 2008, 52 (9): 3161-3168. 10.1128/AAC.00355-08.View ArticlePubMedPubMed CentralGoogle Scholar
- Loivukene K, Naaber P: Antibiotic susceptibility of clinically relevant anaerobes in Estonia from 1999 to 2001. Anaerobe. 2003, 9 (2): 57-61. 10.1016/S1075-9964(03)00041-6.View ArticlePubMedGoogle Scholar
- Jacinto RC, Montagner F, Signoretti FG, Almeida GC, Gomes BP: Frequency, microbial interactions, and antimicrobial susceptibility of Fusobacterium nucleatum and Fusobacterium necrophorum isolated from primary endodontic infections. J Endod. 2008, 34 (12): 1451-1456. 10.1016/j.joen.2008.08.036.View ArticlePubMedGoogle Scholar
- Jamal W, Shahin M, Rotimi VO: Surveillance and trends of antimicrobial resistance among clinical isolates of anaerobes in Kuwait hospitals from 2002 to 2007. Anaerobe. 2010, 16 (1): 1-5. 10.1016/j.anaerobe.2009.04.004.View ArticlePubMedGoogle Scholar
- Gomes BP, Jacinto RC, Montagner F, Sousa EL, Ferraz CC: Analysis of the antimicrobial susceptibility of anaerobic bacteria isolated from endodontic infections in Brazil during a period of nine years. J Endod. 2011, 37 (8): 1058-1062. 10.1016/j.joen.2011.05.015.View ArticlePubMedGoogle Scholar
- Kuriyama T, Williams DW, Yanagisawa M, Iwahara K, Shimizu C, Nakagawa K, Yamamoto E, Karasawa T: Antimicrobial susceptibility of 800 anaerobic isolates from patients with dentoalveolar infection to 13 oral antibiotics. Oral Microbiol Immunol. 2007, 22 (4): 285-288. 10.1111/j.1399-302X.2007.00365.x.View ArticlePubMedGoogle Scholar
- van Winkelhoff AJ, Herrera D, Oteo A, Sanz M: Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain. J Clin Periodontol. 2005, 32 (8): 893-898. 10.1111/j.1600-051X.2005.00782.x.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/12/161/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.